Home › Roche Diagnostics GmbH › Tina-quant Lipoprotein (a) Gen.2 Molarity
Tina-quant Lipoprotein (a) Gen.2 Molarity
Roche Diagnostics GmbH · Model 05852633160 · UDI-DI 07613336237403
DFC
Prescription
1
510(k) clearances
37
Adverse events
6
Recalls
26
Facilities
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2024-12-20 | Randox Laboratories, Limited | Lipoprotein (a) on Roche Cobas c501 with nmol/l claims does not have a 510(k) or PMA. |
| 2024-12-20 | Randox Laboratories, Limited | Lipoprotein (a) on Roche Cobas c501 with nmol/l claims does not have a 510(k) or PMA. |
| 2018-05-16 | Abbott Laboratories, Inc | An update to the Reagents and Specimen Collection and Handling/Preparation for Analysis sections of the IFU was required due to different issues with the various products. |
| 2012-01-30 | Wako Chemicals USA, Inc. | In-vitro diagnostic kit calibrator is defective and could impact patient profile for cardiovascular disease. |
| 2005-01-10 | Diasorin Inc. | QC testing of the Antibody Reagent Set for Lp(a) SPQ Test System it was discovered that the background was failing high of the specification. Through substitution testing it was d |
| 2004-03-29 | Kamiya Biomedical Company | Assay result not consistent with the assigned control value |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.